Table 1:
Maternal Characteristics at Enrollment
| Treatment arm | |||||
|---|---|---|---|---|---|
| Characteristic | PCV-10 (N=115) | PPV-23 (N=115) | Placebo (N=116) | Total (N=346) | |
| Race | Black | 51 (44%) | 57 (50%) | 61 (53%) | 169 (49%) |
| White | 24 (21%) | 19 (17%) | 25 (22%) | 68 (20%) | |
| American Indian | 0 (0%) | 0 (0%) | 1 (1%) | 1 (0%) | |
| Other | 40 (35%) | 36 (31%) | 28 (24%) | 104 (30%) | |
| Unknown | 0 (0%) | 3 (3%) | 1 (1%) | 4 (1%) | |
| Ethnicity | Hispanic or Latino | 112 (97%) | 110 (96%) | 113 (97%) | 335 (97%) |
| Not Hispanic or Latino | 1 (1%) | 1 (1%) | 1 (1%) | 3 (1%) | |
| Unknown | 2 (2%) | 4 (3%) | 2 (2%) | 8 (2%) | |
| Age at randomization (years) | Mean (SD) | 27.3 (6.1) | 27.7 (6.2) | 27.8 (6.2) | 27.6 (6.1) |
| Gestational age (wks) | Median (Q1-Q3) | 26 (22–30) | 26 (21–30) | 25.5 (22–30) | 26 (22–30) |
| CD4+ T cells per μL | Median (Q1-Q3) | 568 (433–742) | 528 (405–745) | 513.5 (366–715.5) | 547.5 (399–732) |
| CD4+ T cells >200 cells per μL | Number (%) | 109 (95%) | 113 (98%) | 107 (92%) | 329 (95%) |
| RNA copies per mL of plasma | Median (Q1-Q3) | 39 (39–96) | 39 (39–103) | 39 (39–57) | 39 (39–90) |
| RNA < 40 copies per mL of plasma | Number (%) | 72 (63%) | 69 (62%) | 81 (71%) | 222 (64%) |